|
|
 |
|
Viewing report
|
|
 |
 |
Business Intelligence in Local Government in Australia and New Zealand
Technology Indicators, Sep 2010, Pages: 34
The requirement for open government practices puts additional pressure on local councils to review and improve their BI capabilities. Comparative peer data presented in this report enable the comparison of the “top 10%” best-performing local councils who make very good (or excellent) use of BI and their less successful peers.
The report provides insights into technical and organizational factors that influence the use of BI and covers the following areas: - organizational BI capabilities across local councils, - external and internal use of council data, - business value of BI technologies, - BI user take-up rates, - BI utilization by business function, - BI deployment considerations and lessons learned, - benefits realization, - organizational risks, - risk / benefits profiles of new BI product deployments and system upgrades, - BI system support requirements, - adoption of emerging BI technologies, - data integration and data integrity across local councils.
This report aims to assist local councils with priority-setting and BI road map development. The report will also enable ICT vendors and consultants who provide BI products and services to better evaluate, validate and calibrate their product development and positioning strategies.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
BioImaging Technologies - Global Strategic Business Report
Data Integration in Life Sciences Companies
16th International Conference: Biodetection Technologies 2010: Technological responses to Biological Threats Webcast and Proceedings
Bioinformatics in Drug Discovery
The Global Bioinformatics Market: Market Size, Forecasts and Company Profiles
Advances in Mass Spectrometry
Advances in Human-Machine Interface Technologies (Technical Insights)
The Future of BioSciences: Four Scenarios for 2020 and their Implications for Human Healthcare
Biotech Life Sciences: A 20/20 Vision to 2020
Assessment of Innovations in Biochips
|
 |
|
|